HHS, along with leading clinicians, researchers, and policy experts, has established a standard clinical definition for opioid withdrawal in infants. Additionally, they have created a set of foundational principles that highlight bioethical uses for the definition that focus on identifying clinical and supportive care needs for mothers and their infants.

A new report published by CDC reveals that medical examiners are seeing a growing number of overdose deaths linked to two opioids: parafluorofentanyl and metonitazene. These drugs are frequently taken or blended with fentanyl and are said to be more powerful than fentanyl.

A review in Antimicrobial Agents and Chemotherapy found that the antibiotic development pipeline has comparatively few clinically differentiated products in late-stage clinical development, particularly against critical, multidrug-resistant pathogens.

Nearly 80% of patients said they see pharmacists as an integral part of their health care team, according to a new survey from Columbia University Mailman School of Public Health.

FDA is drawing attention to dental problems linked to buprenorphine-containing medications that are dissolved under the tongue or placed against the inside of the cheek to treat opioid use disorder and pain.